Brief: Sino Biopharmaceutical Says Disposal Of Equity Interest In Cp Qingdao
06/02/2024 15:30
Feb 6 (Reuters) - Sino Biopharmaceutical 1177.HK :
* DISPOSAL OF EQUITY INTEREST IN CP QINGDAO
* DEAL FOR AGGREGATE CONSIDERATION OF RMB1,819.72 MILLION
* AGREED TO SELL 67% OF REGISTERED CAPITAL OF CP QINGDAO
* SEES GAIN ON DISPOSAL OF RMB1,600 MILLION (NET OF TAXES)
* UNIT SIGNED DISPOSAL DEAL WITH QINGDAO OCEAN NEW KINETIC
ENERGY
PRODUCTS INVESTMENT FUND, AMONG OTHERS
Source text for Eikon: ID:n11065384-1
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up